Market Cap

Prostatype Genomics AB Market Capitalization:

kr28.3 Million

SEK as of Jan. 1, 2024

US$2.8 Million

business Prostatype Genomics AB Company Profile

Prostatype Genomics AB Main Stock Listing

OMX: PROGEN

Market Capitalization History of Prostatype Genomics AB

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $207.62 B
Danaher $171.89 B
Siemens Healthineers AG $66.05 B
DexCom, Inc. $46.50 B
IDEXX Laboratories, Inc. $44.72 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Prostatype Genomics AB market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr28.3 M -41.86%
Jan. 1, 2023 kr48.7 M -74.81%
Jan. 1, 2022 kr193.3 M -50.74%
Jan. 1, 2021 kr392.5 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Prostatype Genomics AB Categories

Sweden languages Healthcare languages Diagnostics & Research
Sweden Healthcare Sweden Diagnostics & Research

Stocks & Indices

Prostatype Genomics AB has the following listings and related stock indices.


Stock: OMX: PROGEN

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.